CEO lifts stake in Bulgarian drug maker Sopharma

Donev acquired the shares through deals on the Bulgarian Stock Exchange on September 18, Sopharma said in a bourse filing.

Donev has been actively acquiring small packages of Sopharma shares since the start of September. Since then, Donev has made only one sale, of 3,620 shares.

At the end of June, Donev held a stake of below 5% in Sopharma, according to the company's most recent interim financial statement.

However, Ognyan Donev is indirectly the biggest shareholder in Sopharma, as he controls a 25.39% stake through his company Donev Investments Holding. Donev is also a major shareholder in Sopharma's second biggest shareholder - Telecomplect Invest. Telecomplect Invest controls 20.68% interest in Sopharma.

Sopharma shares closed at 3.46 levs on the Bulgarian Stock Exchange on Wednesday.

(1 euro = 1.95583 levs)